EuroscreenFast is exhibiting at the EFMC International Symposium on Medicinal Chemistry!

EuroscrenFast is pleased to announce that it will be attending the biennial EFMC Medicinal Chemistry 2026 taking place in Basel, Switzerland, from 6 – 10 September.

This meeting brings together experts from both industry and academia working at the forefront of medicinal chemistry and drug discovery.

This year, EuroscreenFast be co-exhibiting with their friends at AsedaSciences, showcasing the 3RnD® platform and exploring how GPCR interactions can contribute to toxicity and safety risks. Any early understanding of these interactions is incredibly valuable to successful drug development.

If you are also attending EFMC please do get in touch and arrange a meeting – EuroscreenFast’s Commercial Director, Brett Whitecross, will be onsite throughout the event and would be delighted to discuss toxicology screening and what it means for your discovery programs.

🔗 https://www.efmc-ismc.org/